Don’t Jump to Topical Vtama or Zoryve for Psoriasis

October 2022

Vtama (tapinarof) and Zoryve (roflumilast) will be two new once-daily Rx creams for psoriasis.

Both will be touted as steroid-free options that are safe for long-term use, even on thin-skinned areas (face, groin, etc).

But they each reduce inflammation differently.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote